TATA Health International Holdings Limited (HKG:1255)

HKG:1255 Financials Overview

Financials in millions HKD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	99.8	99.8	129.68	207.54	144.61	160.93
Revenue Growth	0.31%	-23.04%	-37.52%	43.52%	-10.14%	3.58%
Gross Profit Gross Profit Growth	80.26	80.26	90.17	150.76	113.94	104.72
Operating Income Operating Income Growth	-23.19	-23.19	-33.96	-31.54	-31.67	-58.2
Net Income Net Income Growth	13.35	13.35	-68.34	-32.29	8.05	-60.76
Earnings Per Share EPS Growth	0.05	0.05	-0.28	-0.13	0.03	-0.26
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Hong Kong Hong Kong Growth	89.64	89.64	112.88	190.64	135.06	148.23
Macau Macau Growth	10.16	10.16	16.8	16.8	8.87	10.24
Total Total Growth	99.8	99.8	129.68	207.54	144.61	160.93

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	17.92	17.92	23	40	33.65	47.04
Total Debt Total Debt Growth	30.64	30.64	42.47	60.97	51.03	52.68
Net Cash (Debt) Net Cash Growth	-12.72	-12.72	-19.47	-20.97	-17.38	-5.65
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.05	-0.05	-0.08	-0.09	-0.07	-0.02

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-16.99	-16.99	1.24	37.79	13.01	-4.9
Capital Expenditures CapEx Growth	-3.81	-3.81	-4.79	-3.99	-0.89	-1.08
Free Cash Flow Free Cash Flow Growth	-20.79	-20.79	-3.56	33.8	12.12	-5.98
Free Cash Flow Growth	-	-	-	178.86%	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	80.43%	80.43%	69.53%	72.64%	78.80%	65.07%
Operating Margin	-23.24%	-23.24%	-26.19%	-15.20%	-21.90%	-36.17%
Pretax Margin	14.02%	14.02%	-52.46%	-17.07%	1.73%	-42.97%
Profit Margin	13.38%	13.38%	-52.70%	-15.56%	5.56%	-37.76%
FCF Margin	-20.84%	-20.84%	-2.74%	16.28%	8.38%	-3.71%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	44.02	23.65	-	-	26.56	-
P/FCF Ratio	-	-	-	2.30	17.63	-
PS Ratio	5.89	3.16	0.56	0.37	1.48	2.40

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 29, 2026

Data Sources Report a data error